amylase 98400 UNT / lipase 16800 UNT / protease 56800 UNT Delayed Release Oral Capsule
RxNorm concept 1806924, clinical drug (scd). Prescribable name: lipase 16,800 UNT / amylase 98,400 UNT / protease 56,800 UNT Delayed Release Oral Capsule.
- RxCUI
- 1806924
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1806924 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
amylase 98,400 UNT / lipase 16,800 UNT / protease 56,800 UNT Delayed Release Oral Capsule; amylases 98,400 UNT / endopeptidases 56,800 UNT / lipase 16,800 UNT Delayed Release Oral Capsule
Related concepts
- lipase 16800 UNT (SCDC, consists of)
- amylase 98400 UNT (SCDC, consists of)
- protease 56800 UNT (SCDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- amylase 98400 UNT / lipase 16800 UNT / protease 56800 UNT Delayed Release Oral Capsule [Pancreaze] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1806924 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1806924 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1806924. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.